ESOU 2021: Surgical and Perioperative Challenges of Large Renal Tumors
(UroToday.com) At the European Association of Urology (EAU) Section of Oncological Urology (ESOU) 2021 virtual meeting, Dr. Arnaud Mejean discussed surgical and perioperative challenges of large renal tumors, particularly those with vena cava and lymph node involvement. Dr. Mejean notes that statistics from the SEER database suggest that 19% of patients present with locoregional disease, making this an important area of management. Historical data from an international multicenter study shows that based on UCLA Integrated Staging System (UISS) stratification for localized renal cell carcinoma (RCC), the 5-year survival rates were 92%, 67%, and 44% for low-, intermediate-, and high-risk groups, respectively.
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Biofidelity appoints Wendy J. Levin MD MS as Chief Medical Officer
Biofidelity LimitedJanuary 28, 2021 GMT
Experienced US-based medical oncologist joins Biofidelity prior to launch of first diagnostic product
US-trained oncologist & hematologist with over 15 years industry experience in translational medicine and drug development
Global clinical lead for the Pfizer SMO Inhibitor,
Daurismo, from pre-IND to FDA approval
Clinical development and medical affairs leadership for multiple publicly-traded and private companies
CAMBRIDGE, United Kingdom, Jan. 28, 2021 (GLOBE NEWSWIRE) Biofidelity Ltd, the cancer diagnostics company, today announces the appointment of Wendy J. Levin MD MS as Chief Medical Officer, based in the US. Following Biofidelity’s recent Series A financing, supported by experienced investors BlueYard Capital, Longwall Ventures and Agilent Technologies, the
· Global clinical lead for the Pfizer SMO Inhibitor, Daurismo, from pre-IND to FDA approval · Clinical development and medical affairs leadership for multiple publicly-traded and private companies Cambridge, UK 28 January 2021 - Biofidelity Ltd, the cancer diagnostics company, today announces the appointment of Wendy J. Levin MD MS as Chief Medical Officer, based in the US. Following Biofidelity s recent Series A financing, supported by experienced investors BlueYard Capital, Longwall Ventures and Agilent Technologies, the Company is now focused on expanding its executive team as it works towards launch of the Identi-Lung panel in 2021. Dr. Levin s appointment follows those of former Roche executive Heiner Dreismann as Chairman, Stephen Miller as Chief Commercial Officer and Robert Osborne as Chief Operating Officer.
Co-Chair Of State Vaccine Task Force Says California Has New COVID-19 Inoculation Scheduling System
COVID-19 inoculations haven’t come quickly enough, the co-chair of California’s vaccination task force admitted in a State Sen. Mike McGuire town hall meeting Tuesday.
Lori Nezhura, deputy director of planning, preparedness and prevention for the California Offices of Emergency Services, acknowledged the confusion around who is eligible to receive the vaccine currently. She pointed Northern California residents to a new scheduling system, MyTurn.ca.gov.
“Starting today, people will be able to leave their contact information so they can be notified when it’s their turn,” Nezhura said. “Right now we are piloting the system in Los Angeles and San Diego people can use My Turn to determine eligibility and make an appointment. Our hope is the appointment-setting capability will be statewide by the beginning of February.”
By Nina Notman2021-01-26T09:43:00+00:00
Devices made from nucleic acids are starting to find their feet, says Nina Notman
The human body hosts millions of molecular motors and other machines. They keep our lungs breathing, our hearts beating, our brains thinking and our digestive systems gurgling. ‘Life is just amazing. The more we learn about all the incredible functionality that’s present on a microscopic level of life, the more many of us are filled with the desire to be able to recapitulate similar kinds of functionality synthetically,’ says William Shih, a biochemistry professor at Harvard University in Massachusetts, US.